Technologies at Boehringer Ingelheim
The need for innovative technologies to accelerate pharmaceutical research and development has never been greater. Seeking to be at the forefront of cutting-edge science, Boehringer Ingelheim is expanding its growing global network of technology partners to complement its own expertise in research, development and translational medicine.
Scientists at our three major research sites in Biberach (Germany), Ridgefield (CT, USA) and Vienna (Austria), together with their academic and industry partners, are pursuing novel technologies to support therapeutic advances in areas of key unmet medical need. They have the ambition to identify and translate the most promising technology innovations into impactful applications across a broad range of research fields.